Barel M, Gauffre A, Lyamani F, Fiandino A, Hermann J, Frade R
Immunochimie des Antigènes de Membrane et des Interactions Cellulaires, Centre INSERM, Hôpital Saint-Antoine, Paris, France.
J Immunol. 1991 Aug 15;147(4):1286-91.
To analyze direct intracellular interactions of CR2 in normal human B lymphocytes, we used polyclonal anti-Id anti-CR2 antibodies (Ab2) prepared against the highly purified CR2 molecule (gp140) as original immunogen. We previously demonstrated that this Ab2 contained specificities that mimicked extracellular and intracellular domains of CR2 and was helpful for identifying CR2-specific ligands. Indeed, some Ab2 specificities recognized human C3d and EBV, two extracellular CR2 ligands. In addition, other Ab2 specificities interacted directly, as CR2, with the intracellular p53 antioncoprotein that is expressed in transformed cells and not in normal cells. We demonstrate herein that Ab2 detected in normal B lymphocytes a 68-kDa protein, p68, that was not expressed in transformed B cells. p68 was localized in purified plasma membranes and cytosol fractions. Direct interaction of purified CR2 with purified p68 was demonstrated. Competitive studies supported that CR2 and Ab2 interacted with identical sites on p68. These interactions were calcium dependent. p68 was identified as a calcium-binding protein by its ability to be solubilized from B lymphocyte membranes by EGTA, a calcium-chelating agent, to bind specifically on phenothiazine-Sepharose in a calcium-dependent interaction, and to be recognized by specific antibodies directed against human p68, a calcium-binding protein of the annexin VI family. Thus, demonstration of different intracellular interactions of CR2 with distinct regulatory proteins, such as p53, the antioncoprotein, and p68, a calcium-binding protein, supports involvement of two regulatory pathways of signal transduction through CR2, depending on the normal or transformed state of human B lymphocytes.
为了分析正常人B淋巴细胞中CR2的直接细胞内相互作用,我们使用了以高度纯化的CR2分子(gp140)作为原始免疫原制备的多克隆抗独特型抗CR2抗体(Ab2)。我们之前证明,这种Ab2包含模拟CR2细胞外和细胞内结构域的特异性,有助于鉴定CR2特异性配体。实际上,一些Ab2特异性识别两种细胞外CR2配体——人C3d和EBV。此外,其他Ab2特异性像CR2一样直接与转化细胞而非正常细胞中表达的细胞内p53抗癌蛋白相互作用。我们在此证明,Ab2在正常B淋巴细胞中检测到一种68 kDa的蛋白p68,而转化B细胞中不表达该蛋白。p68定位于纯化的质膜和胞质溶胶组分中。证明了纯化的CR2与纯化的p68直接相互作用。竞争性研究支持CR2和Ab2与p68上的相同位点相互作用。这些相互作用依赖于钙。通过用钙螯合剂EGTA从B淋巴细胞膜中溶解、在依赖钙的相互作用中特异性结合吩噻嗪-琼脂糖以及被针对人p68(膜联蛋白VI家族的一种钙结合蛋白)的特异性抗体识别的能力,p68被鉴定为一种钙结合蛋白。因此,CR2与不同调节蛋白(如抗癌蛋白p53和钙结合蛋白p68)之间不同细胞内相互作用的证明,支持了根据人B淋巴细胞的正常或转化状态,通过CR2的两条信号转导调节途径的参与。